Wings Therapeutics Wings Therapeutics is a biotechnology company engaged in the development of therapies for patients suffering from Dystrophic Epidermolysis Bullosa (DEB), a rare genetic skin blistering disease. | ||
Founding Date | Founding Date 2019 | Founding Date 1992 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Berkeley, US HQ | Locations Somerville, US HQ |
Employees | Employees 5 | Employees 32338% decrease |
Funding | ||
Total funding raised | Total funding raised $ 1.5m | Total funding raised $ 409m |

Bluebird Bio is a developer of gene therapies for severe genetic diseases.
View company